BiomX Inc. — Director's Dealing 2020

Mar 27, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BiomX Inc. (PHGE)
CIK: 0001739174
Period of Report: 2020-03-25

Reporting Person: Oron Assaf (Chief Business Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-03-25	Common Stock Options - Right to Buy	$6.21	A	31500	Acquired	2030-03-25	Common Stock (31500)	Direct

Footnotes

F1: The options vest and become exercisable over four years, with 25% of the shares subject to the option vesting on March 25, 2021, and the remainder vesting in 12 equal quarterly installments over three years.

F2: Does not include 284,996 additional options previously granted to the Reporting Person which have different exercise prices and which vest on different schedules.